Common Sense Oncology

[Common Sense Oncology @csoncol]

Catch up on Common Sense Oncology's latest projects and priorities—watch the recording from our session at London Global Cancer Week 2026 on YouTube: https://t.co/IrwIUqiltu

#CommonSenseOncology #CancerCare #LGCW2026

@MichelleTregear, @hafaydeefe

[Common Sense Oncology @csoncol]

In this episode of the Common Sense Oncology podcast, doctors @drbrookewilson, Chris Booth, @hafaydeefe, and patient advocate Carolyn Taylor discuss the new breakthrough pancreatic cancer drug Daraxonrasib, and what its price tag of $40,000 USD per month, or $56,300 CAD per month, means for patients in North America and across the globe.

Listen on your favourite platform:
Spotify: https://t.co/t4dgctwTl8
Apple: https://t.co/rY1EEAjWLQ

#CommonSenseOncology #CancerCare #Daraxonrasib

[Common Sense Oncology @csoncol]

Reminder to join CSO online on November 16th at 2 pm (EST) for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access.

Register now: https://t.co/4ec8b9zl4g

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

Join CSO on November 16th for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access.

Where: Online (Zoom)
When: Monday, November 16, 2026 at 2:00 pm (EST) / 1:00 pm (CST) / 12:00 pm (MST)
Speakers: Dr. Ian Tannock, Dr. Chris Booth, Dr. Sharlene Gill, Carolyn Taylor, Dr. Ramy Sedhom

Register now: https://t.co/4PnvFG21Cn

#CommonSenseOncology #CancerCare #Daraxonrasib

[Common Sense Oncology @csoncol]

Cancer trials increasingly measure quality of life. But are we asking—and answering—the questions patients really need answered?

What are the chances a treatment will make me feel better or worse? How will it affect my ability to function? How long might those effects last? And how do we weigh quality of life against the potential benefits of treatment?

Join Drs. Madeline Pe, Ian Tannock, and Michael Brundage on November 13 at 11 a.m. ET for a high-level conversation about making quality-of-life evidence more meaningful for patients, followed by an extended panel discussion and Q&A.

Register here: https://t.co/e3PJt2mYBS

#CommonSenseOncology #CancerCare @MichelleTregear

[Common Sense Oncology @csoncol]

Join CSO on November 16th for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access.

Where: Online (Zoom)
When: Monday, November 16, 2026 at 2:00 pm (EST) / 1:00 pm (CST) / 12:00 pm (MST)
Speakers: Dr. Ian Tannock, Dr. Chris Booth, Dr. Sharlene Gill, Carolyn Taylor, Dr. Ramy Sedhom

Register now: https://t.co/4PnvFG21Cn

#CommonSenseOncology #CancerCare #Daraxonrasib

[Common Sense Oncology @csoncol]

The CSO Symposium at Kenya Society of Haematology & Oncology (KESHO) is taking place on Thursday, November 19th in Mombasa, Kenya! Register for the conference here: https://t.co/VhbE0C5Lhg

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

CSO and oncologists across Canada are speaking out about escalating cancer drug costs after the recent U.S. pricing announcement for the new pancreatic cancer drug daraxonrasib. The list price of CAD$56,300 per month means it will be inaccessible to many patients and health systems, and risks turning a breakthrough treatment into an unfulfilled promise to cancer patients.

Watch the segment on daraxonrasib from CBC's The National for more: https://t.co/B0jFtcESNm

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

Join CSO this Thursday, November 5th online for London Global Cancer Week! Register here: https://t.co/EhEnOgI0Y5

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

This is your reminder to catch up with CSO during London Global Cancer Week!

This online session will review progress to date on CSO’s major outputs, work-in-progress, and highlight ways that oncologists, advocates, organisations, and people with lived experience can engage with the CSO initiative.

Where: Online (Zoom)

When: Thursday, November 5, 2026 - 18:30 - 20:00 (GMT) | 1:30 pm - 3:00 pm (EST)
Speakers: Dr. Christopher Jackson, Dr. Ian Tannock, Dr. Manju Sengar, Dr. Haydeé Verduzco, Dr. Michelle Tregear

RSVP at the following link: https://t.co/iAvL6ZQRuU

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

The development of innovative new cancer medicines that meaningfully improve patient survival and quality of life is to be celebrated. But a new commentary from Common Sense Oncology published in The Lancet Oncology warns that spiraling prices risk turning these new treatments into unfulfilled promises, because they may not be accessible to the patients who need them.

Read more on our website: https://t.co/adNhET0Xoo

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

Thank you for making the Common Sense Oncology event at ESMO in Madrid a success this past Friday! It was a great opportunity for oncologists from around the world to connect over a shared interest in outcomes that matter for cancer patients and health care systems. We look forward to seeing you again at our next event!

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

The CSO Symposium at ESMO is happening today! Join us at 18:00 at IFEMA in Room A6.1. No RSVP required.

See you there!

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

The CSO Symposium at ESMO is happening this Friday, October 23rd! RSVP here: https://t.co/eEAsET6Gyk

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

This is your reminder to catch up with CSO during London Global Cancer Week!

This online session will review progress to date on CSO’s major outputs, work-in-progress, and highlight ways that oncologists, advocates, organisations, and people with lived experience can engage with the CSO initiative.

Where: Online (Zoom)

When: Thursday, November 5, 2026 - 18:30 - 20:00 (GMT) | 1:30 pm - 3:00 pm (EST)
Speakers: Dr. Christopher Jackson, Dr. Ian Tannock, Dr. Manju Sengar, Dr. Haydeé Verduzco, Dr. Michelle Tregear

RSVP at the following link: https://t.co/iAvL6ZQRuU

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

The CSO Symposium at ESMO is happening this Friday, October 23rd! RSVP here: https://t.co/eEAsET6Gyk

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

🚨 CSO at ESMO 2026 is 9 days away!

This is your reminder to attend and hear updates on the movement and regional developments across the globe. Network with likeminded individuals and enjoy light refreshments.

Speakers will give short talks about CSO-aligned activities in their respective countries. There will be time for attendees to ask questions and talk about what’s happening in their own systems.

Where: ESMO venue, IFEMA, Madrid, Spain - Room A6.1
When: Friday, October 23, 2026 - 18:00 - 19:30
Speakers: Dr. Winette van der Graaf, Dr. Dario Trapani, Dr. Chris Booth, Dr. Rodrigo Lastra del Prado, Dr. Francesco Perrone, Dr. Jolien Tol, Antonella Cardone

Planning to attend? RSVP here to let us know! (RSVP is NOT mandatory to attend.) https://t.co/gGZSo597Rs

#CancerCare #CommonSenseOncology

[Common Sense Oncology @csoncol]

🚨 CSO at ESMO 2026 is 9 days away!

This is your reminder to attend and hear updates on the movement and regional developments across the globe. Network with likeminded individuals and enjoy light refreshments.

Speakers will give short talks about CSO-aligned activities in their respective countries. There will be time for attendees to ask questions and talk about what’s happening in their own systems.

Where: ESMO venue, IFEMA, Madrid, Spain - Room A6.1
When: Friday, October 23, 2026 - 18:00 - 19:30
Speakers: Dr. Winette van der Graaf, Dr. Dario Trapani, Dr. Chris Booth, Dr. Rodrigo Lastra del Prado, Dr. Francesco Perrone, Dr. Jolien Tol, Antonella Cardone

Planning to attend? RSVP here to let us know! (RSVP is NOT mandatory to attend.) https://t.co/gGZSo597Rs

#CancerCare #CommonSenseOncology

[Common Sense Oncology @csoncol]

Join CSO at the 2026 Kenya International Cancer Conference! Prof. @VanderpuyeVerna, Dr. @Rubagumyaf, Dr. @HamidMD10, and Prof. Nazik Hammad will be presenting the principles of CSO in the African context. Learn about a range of topics, from the impacts of clinical trials to patient perspectives.

Where: Sarova Whitesands, Mombasa, Kenya
When: November 19th, 11:30 am - 12:30 pm

We hope to see you there!

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

The CHALLENGE Trial demonstrated that patients with colon cancer who followed a structured exercise program had better survival and quality of life outcomes than those who were only given educational information about exercise.

It isn't always enough to tell someone they should exercise, behavioral change often requires assistance from a physical trainer.

It's time to put this into practice! U.P.M.C. Hillman Cancer Center is leading the way in the USA by offering an exercise program for breast cancer patients beginning next year. If it's successful, the hospital plans to expand the program to all cancers in 2028.

Read the full story in the New York Times:  https://t.co/efU3Xx3KOf

#CommonSenseOncology #CancerCare

[Common Sense Oncology @csoncol]

Catch up with CSO during London Global Cancer Week!

This session will review progress to date on CSO’s major outputs, work-in-progress, and highlight ways that oncologists, advocates, organisations, and people with lived experience can engage with the CSO initiative.

Where: Online (Zoom)

When: Thursday, November 5, 2026 - 18:30 - 20:00 (GMT) | 1:30 pm - 3:00 pm (EST)

Speakers: Dr. Christopher Jackson, Dr. Ian Tannock, Dr. Manju Sengar, Dr. Haydeé Verduzco, Dr. Michelle Tregear

RSVP at the following link: https://t.co/iAvL6ZQRuU

#CommonSenseOncology #CancerCare